Will a March Help Science?

As scientists and science advocates plan demonstrations in Washington, DC, and around the world, some question the ability of such activism to enact change.

Written byDiana Kwon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WIKIMEDIA

Over the last several days, as President Donald Trump signed one executive order after another, scientists across the U.S. were connecting to prepare a March for Science on Washington, DC. Yesterday, the organizers announced an official date for the demonstration—April 22, Earth Day. But amidst the excitement surrounding the event, some scientists have argued that a march may not be the best way to effect change.

In a widely circulated New York Times opinion article, coastal geologist Robert Young of Western Carolina University argued that the march is “a terrible idea,” as it could deepen the divide between conservatives and liberals, reinforce the idea that scientists are a political interest group, and ultimately increase the size of an existing echo chamber within the community.

“There’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies